What does CUSIP 75629V104 represent in this 13F holders report?

CUSIP 75629V104 is the security identifier for RXRX - RECURSION PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held RXRX - RECURSION PHARMACEUTICALS, INC. - Common Stock in Q3 2021?

82 institutional investors reported RXRX - RECURSION PHARMACEUTICALS, INC. - Common Stock for Q3 2021. Use the holders table for investor-level position and value details.

RECURSION PHARMACEUTICALS, INC. - Common Stock (RXRX)

CUSIP: 75629V104

Q3 2021 13F Holders as of 30 Sep 2021

Security type / class: Equity / Common Stock
Total 13F shares: 54,909,739
Total 13F value: $1,262,978,377
Share change: +7,941,005
Put/Call ratio: 29%
SEC-reported price per share: $23.01
Number of holders: 82
Value change: +$181,552,159
Number of buys: 58
Number of sells: 17
Shares outstanding: 525,448,476

Security key

75629V104

Report period

Q3 2021

Institutions

Top holders

RXRX full security history Ownership snapshot Full 13F holder table RECURSION PHARMACEUTICALS, INC. SEC filings RECURSION PHARMACEUTICALS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of RXRX - RECURSION PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BAILLIE GIFFORD & CO

Disclosed value leader

BAILLIE GIFFORD & CO

Comparable rows

15/15

Latest evidence

30 Jun 2021

13F Lead comparable stake: 3.5% Showing 1-6 of 15 holder rows.

Quick read

BAILLIE GIFFORD & CO leads the comparable SEC ownership view at 3.5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BAILLIE GIFFORD & CO's linked filing trail.

Comparable ownership Top 5

BAILLIE GIFFORD & CO 3.5%

Laurion Capital Management LP 0.73%

VANGUARD GROUP INC 0.51%

ARK Investment Management LLC 0.45%

FMR LLC 0.42%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BAILLIE GIFFORD & CO	13F Company 13F	3.5%	$676,017,000 18,521,000 shares	—	30 Jun 2021
Laurion Capital Management LP	13F Company 13F	0.73%	$140,839,000 3,858,617 shares	—	30 Jun 2021
VANGUARD GROUP INC	13F Company 13F	0.51%	$97,934,000 2,683,107 shares	—	30 Jun 2021
ARK Investment Management LLC	13F Company 13F	0.45%	$86,822,000 2,378,675 shares	—	30 Jun 2021
FMR LLC	13F Company 13F	0.42%	$80,724,000 2,211,601 shares	—	30 Jun 2021
HARVARD MANAGEMENT CO INC	13F Company 13F	0.29%	$55,088,000 1,509,254 shares	—	30 Jun 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

54,909,739

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders

Q3 2021 holders

Holder diff

Investor	Q2 2021 Shares	Q3 2021 Shares	Share Diff	Share Chg %	Q2 2021 value	Q3 2021 value	Value change	Value Chg %